Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 1 |
2015 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.
Cancer Res. 2022 Oct 4;82(19):3435-3448. doi: 10.1158/0008-5472.CAN-22-0325.
Cancer Res. 2022.
PMID: 35930804
Free PMC article.
RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?
Downward J.
Downward J.
Clin Cancer Res. 2015 Apr 15;21(8):1802-9. doi: 10.1158/1078-0432.CCR-14-2180.
Clin Cancer Res. 2015.
PMID: 25878361
Free PMC article.
Review.
Item in Clipboard
HMGA2 functions as a competing endogenous RNA to promote lung cancer progression.
Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, Downward J.
Kumar MS, et al.
Nature. 2014 Jan 9;505(7482):212-7. doi: 10.1038/nature12785. Epub 2013 Dec 4.
Nature. 2014.
PMID: 24305048
Free PMC article.
Retracted.
Item in Clipboard
Cite
Cite